The performance of companies tied to Sildenafil's history presents a intricate investment landscape. While the initial boom generated substantial returns , generic competition have significantly diminished https://bookmark-media.com/story21752821/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity